We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Allele-specific silencing as treatment for gene duplication disorders: proof-of-principle in autosomal dominant leukodystrophy.
- Authors
Giorgio, Elisa; Lorenzati, Martina; Cervo, Pia Rivetti di Val; Brussino, Alessandro; Cernigoj, Manuel; Sala, Edoardo Della; Stella, Anna Bartoletti; Ferrero, Marta; Caiazzo, Massimiliano; Capellari, Sabina; Cortelli, Pietro; Conti, Luciano; Cattaneo, Elena; Buffo, Annalisa; Brusco, Alfredo; Rivetti di Val Cervo, Pia; Della Sala, Edoardo; Bartoletti Stella, Anna
- Abstract
Allele-specific silencing by RNA interference (ASP-siRNA) holds promise as a therapeutic strategy for downregulating a single mutant allele with minimal suppression of the corresponding wild-type allele. This approach has been effectively used to target autosomal dominant mutations and single nucleotide polymorphisms linked with aberrantly expanded trinucleotide repeats. Here, we propose ASP-siRNA as a preferable choice to target duplicated disease genes, avoiding potentially harmful excessive downregulation. As a proof-of-concept, we studied autosomal dominant adult-onset demyelinating leukodystrophy (ADLD) due to lamin B1 (LMNB1) duplication, a hereditary, progressive and fatal disorder affecting myelin in the CNS. Using a reporter system, we screened the most efficient ASP-siRNAs preferentially targeting one of the alleles at rs1051644 (average minor allele frequency: 0.45) located in the 3' untranslated region of the gene. We identified four siRNAs with a high efficacy and allele-specificity, which were tested in ADLD patient-derived fibroblasts. Three of the small interfering RNAs were highly selective for the target allele and restored both LMNB1 mRNA and protein levels close to control levels. Furthermore, small interfering RNA treatment abrogates the ADLD-specific phenotypes in fibroblasts and in two disease-relevant cellular models: murine oligodendrocytes overexpressing human LMNB1, and neurons directly reprogrammed from patients' fibroblasts. In conclusion, we demonstrated that ASP-silencing by RNA interference is a suitable and promising therapeutic option for ADLD. Moreover, our results have a broad translational value extending to several pathological conditions linked to gene-gain in copy number variations.
- Subjects
GENE silencing; SMALL interfering RNA; PLANT gene silencing; SINGLE nucleotide polymorphisms; LEUKODYSTROPHY; TRINUCLEOTIDE repeats; CHROMOSOME duplication
- Publication
Brain: A Journal of Neurology, 2019, Vol 142, Issue 7, p1905
- ISSN
0006-8950
- Publication type
journal article
- DOI
10.1093/brain/awz139